Pediatrics and Genetics, University of Geneva Geneva, Switzerland. Radioimmunoassay of urinary LHRH.
LHRH immunoreactivity in the urine has been reported with suggestions that the excreted product is intact LHRH or a 2-10 or 3-10 fragment. To better elucidate the unclear nature of urinary LHRH, we have developed radioimmunoassay systems utilizing 8 antisera. Using 30 analogs of LHRH, we tested each antiserum for binding characteristics. Three, the highly specific Niswender R-42 and the two Kelch13 antisera appeared to require the entire molecular configuration for activity; two required only 3-4 C-terminal amino acids; and three bound non-specifically to different portions of the sequence. Utilizing the sensitive Kelch13-lo antiserum, basal immunoreactive urinary LHRH in a normal man was 8 pg per ml of unconcentrated urine. After an I.V. injection of 50 pg LHRH, the concentration of urinary immunoreactive LHRH was 430 pg/ml in the first hour. An excretion rate of 101 ng/hr was found in the first hour, falling to 6.5 ng/hr by the 4th hour, with a total of 150 ng excreted in 4 hours. It is concluded that LHRH immunoreactivity is detectable in the urine The bo/b+thal.,was observed in 11(37%) and the b+/b+thal.,in 7 (23%).
It is concluded that both b0and b ' c i e n e s are common in Greece and chromatographic analysis helps to determine the in the basal state and afEer a bolus injection.
genotype. Prolactin (PR) and TSH responses to IV TRH (0.2 mg/m2) were studied in 49 hGH deficient children (33 boys, 16 girls): 29 tumoral hypopituitarisms (TH) including 20 craniopharyngioma (5 before and 15 after surgery) and 20 idiopathic hypopituitarisms (IH). Results were expressed as ng/ml of NIH hPR F3. In IH, the mean PR basal value was 19.8 (range from non detectable ND to 60); 5 values were above the 95 th. percentile of normal range; the mean peak value was 41.6 (range 5 -114, 6 values were under the 5 th. percentile). In CP, the mean PR basal value was 6.9 (range ND -16) and the mean peak value was 15.8 (range ND -33, 12 values under the 5 th. percentile). In other TH, the mean basal value was 21.9 (range 3 -55) and the mean peak value was 42 (range 9 -90, 3 values under the 5 th. and 3 values above the 95 th. percentiles). In both groups no correlation was found between PR responses and TSH responses or thyroxine (T4) levels. However, in IH normal or high PR responses were always associated with normal or high TSH responses, while low T4 levels were encountered in 7 subjects of this subgroup. In CP, low PR responses with low TSH responses and low T4 levels were observed only after surgical removal. These data demonstrated that PR response to TRH is normal in about 50 % of hGH deficient children, while low responses are frequently observed in CP before and after surgery. Elevated basal and peak levels in some IH or TH lead to speculate a prolactostatin (PIF) deficiency. 12 homozygote patients and 32 heterozygous-genecarriers from families with cystic fibrosis /CF/ were HLA-typed for 29 HLA-antigens.The HLA-B18 proved to be more frequent in the groups of homo-and heterozygotesl 50 and 31 per cent respectively compared with 14 pe$ cent in a control group of 130 healthy blood donors .
Serum and salivary amylase activity were investigated with the using of Phadebas-amylase method.The average of total amylase activity in serum was 269 U/1+113,7, in the CF homozygotes'group, in the heterozygot~s'group was similar as in the healthy persons /210.7 U/1+86/. The CF hogozygotes' salivary amylase activity was morq ineleased /148.7 U/1+65.1/ than in the heterozygotes' group /118.2+67.0/ a% in the control ones /97.7+34.9/ The salivary-amylase activity was moderately eleyated in the cases of CF heterozygotes without the change of the serum total amylase activity.The amylase isoenzymes were identificated with flat-bed polyacrylamide gel-e1ectrophoresis.Significant differences have been found in the distribution of amylase isoenzymes too. The diagnosis of mucoliuidosis I1 in a oregnancy at risk by studies on amniotic materials.
Mucolipidosis I1 (ML I1,I-cell disease) is a fatal inborn error of metabolism with altered levels of certain lysosomal hydrolases.In a nregnancy at risk,in which ML I1 was suspected,r?e were able to monitor the activity of several lysosomal hydrolases in cultured amniotic fluid cells and in amniotic fluid.In amniotic fluid an increase in hydrolase activity was observed, whereas cultured amniotic cel showed a decrease,together w h a n accumulation of 3'S-labeled ~lycosaminoqly. cans ("S gA~s).The ilreznancy was therefore interrupted in the 22" gestational veek.The diagnosis was clearly confirmed by analysis of material from the aborted fetus.In fetal serum the activities of several lysosomal hydrolases were elevated awaroximately 10 to 70-fold, whereas the enzyme levels in fetal fibroblasts were con. siderabl reduced.There was also an excessive accumulation of Y5S GAGS in fetal fibroblasts.0ur results,and those of others (Aula et al,J.Pediat.87,1975;Huijing et al,Clin.Chirn.Acta hk,l973;Matsuda et X,13umangenetik 2 1975),indicate that increased levels of these enzymes in amniotic fluid may suffice as a prenatal diagnosis of ML II.However,due to considerable variations het:?een individual samnles,the diagnosis should so be confirmed by analyses of these enzymes and by "S incorporation studies in cultured amniotic cells.
